Skip to main content
. 2015 Dec 1;50(4):217–225. doi: 10.5152/TurkPediatriArs.2015.2827

Table 1.

Comparison of the clinical and laboratory features of influenza and other respiratory tract viruses

RTI related with influenza viruses (n=70) RTI related with non-influenza viruses (n=70) p
Age, median (the lowest-the highest) 6.5 (2.5–16.0) 4.5 (2.5–14.0) <0.001
Gender, male/female n (%) 46/24 (65.7/34.3) 36/34 (51.4–48.6) 0.086
Age group, n (%)
  2–5 years 27 (38.6) 42 (60) 0.011
  >5 years 43 (61.4) 28 (40)
Indoor exposure to smoking, n (%) 24 (34.3) 22 (31.4) 0.719
School/kindergarten, n (%) 58 (82.9) 41 (58.6) 0.002
Number of siblings, ≥2, n (%) 25 (35.7) 34 (48.6) 0.123
Contact with URTI, n (%) 44 (62.9) 34 (48.6) 0.089
Clinical Diagnosis, n (%)
  URTI 45 (64.3) 47 (67)
  Acute bronchitis 11 (15.7) 9 (12.9)
  Bronchopneumoniae 11 (15.7) 6 (8.6) 0.382
  Pneumoniae 2 (2.9) 4 (5.7)
  Bronchiolitis 1 (1.4) 4 (5.7)
  Presence of underlying disease, n (%) 17 (24.3) 11 (15.7) 0.205
  Influenza-like illness, n (%) 66 (94.3) 52 (74.3) 0.001
Radiology, n (%) (s=31) (s=28)
  Normal 13 (18.6) 13 (18.6)
  Peribronchial infiltration 12 (17.1) 11 (15.7)
  Consolidation 5 (7.1) 3 (4.3) 0.663
  Increased aeration 1 (1.4) 1 (1.4)
  Atelectasis - 1 (1.4)
Laboratory, median (the lowest-the highest) (n=59) (n=58)
  Leukocytes 7 500 (3 020–31 390) 10 250 (3 500–25 500) <0.001
  Neutrophils 3 910 (700–27 720) 5 730 (1 400–23 200) 0.038
  Lymphocytes 1 950 (500–6 100) 2 450 (450–10 470) 0.006
  CRP 7 (0–74) 18 (0–200) 0.001
Hospitalization, n (%) 15 (21.4) 19 (27.1) 0.430
Hospitalization in ICU, n (%) 2 (2.9) 1 (1.4) 0.559
Hospitalization time, days, median (the lowest-the highest) 6 (2–12) 5 (1–18) 0.767
Disease time, days, median (the lowest-the highest) 7 (4–14) 6 (4–21) 0.078

CRP: C reactive protein; ICU: intensive care unit, n: number; RTI: respiratory tract infections